NUVB - Nuvation Bio GAAP EPS of -$0.09 beats by $0.02 August, 03 2023 05:57 PM Nuvation Bio Inc. Class A 2023-08-03 17:57:20 ET Nuvation Bio press release ( NYSE: NUVB ): Q2 GAAP EPS of -$0.09 beats by $0.02 . As of June 30, 2023, Nuvation Bio had cash, cash equivalents and marketable securities of $630.9 million. For further details see: Nuvation Bio GAAP EPS of -$0.09 beats by $0.02